Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL) 16 February 2022
Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY) 14 February 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview)
Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital 7 October 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 29 September 2020
GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital 25 September 2020
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 35% Upside Potential with Strong Buy Ratings 20 January 2026
Auction Technology Group PLC (ATG.L) Stock Analysis: Navigating the 26.51% Upside Potential 20 January 2026
Hilton Food Group PLC (HFG.L) Investor Outlook: 52.39% Potential Upside Highlights Growth Prospects 20 January 2026
Baltic Classifieds Group PLC (BCG.L) Stock Analysis: Unlocking a Potential 41% Upside 20 January 2026
Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL) 16 February 2022
Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY) 14 February 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview)
Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital 7 October 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 29 September 2020
GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital 25 September 2020
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 35% Upside Potential with Strong Buy Ratings 20 January 2026
Auction Technology Group PLC (ATG.L) Stock Analysis: Navigating the 26.51% Upside Potential 20 January 2026
Hilton Food Group PLC (HFG.L) Investor Outlook: 52.39% Potential Upside Highlights Growth Prospects 20 January 2026
Baltic Classifieds Group PLC (BCG.L) Stock Analysis: Unlocking a Potential 41% Upside 20 January 2026
Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Navigating a 55.66% Potential Upside in Biotech 19 December 2025
KalVista Pharmaceuticals, Inc. (KALV): Analyst Consensus Reveals Over 100% Potential Upside 19 December 2025
Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 217.58% Potential Upside 19 December 2025
Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 239% Upside Potential in Innovative Cancer Therapies 19 December 2025
Eton Pharmaceuticals (ETON) Investor Outlook: Exploring an 87% Potential Upside in the Rare Disease Market 19 December 2025
Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unpacking the 84.65% Potential Upside for Investors 19 December 2025
GH Research PLC (GHRS) Stock Analysis: Exploring a 138.80% Upside in the Biotech Sector 19 December 2025
Xencor, Inc. (XNCR) Investor Outlook: An 80% Upside Potential in the Biotech Frontier 19 December 2025
Pharvaris N.V. (PHVS) Stock Analysis: Potential Upside of Over 90% Beckons Investors 19 December 2025
Sionna Therapeutics, Inc. (SION) Stock Analysis: Strong Buy Ratings Amidst Promising Cystic Fibrosis Pipeline 19 December 2025
Embecta Corp. (EMBC) Stock Analysis: Exploring a 42% Potential Upside in the Healthcare Sector 19 December 2025
SI-BONE, Inc. (SIBN) Stock Analysis: A Robust 27.85% Potential Upside Beckons Investors 19 December 2025
Arcus Biosciences, Inc. (RCUS) Stock Analysis: Unveiling a 45.98% Upside Potential Amidst Clinical Innovations 19 December 2025
RxSight, Inc. (RXST) Stock Analysis: Navigating a -16.06% Potential Downside with Innovative Technology 19 December 2025
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Strong Revenue Growth and Promising Analyst Ratings 19 December 2025
uniQure N.V. (QURE) Stock Analysis: Unveiling a 131% Potential Upside in the Biotech Sector 19 December 2025
Immunome, Inc. (IMNM) Stock Analysis: Unveiling a 71.68% Upside Potential in the Fast-Paced Biotech Sector 19 December 2025
Maravai LifeSciences Holdings (MRVI) Stock Analysis: An 11.61% Upside in the Biotech Sector 19 December 2025
CeriBell, Inc. (CBLL) Stock Analysis: 31.82% Upside Potential and Strong Buy Ratings 19 December 2025
Spyre Therapeutics (SYRE) Stock Analysis: Uncovering a 62.49% Potential Upside in Biotechnology 19 December 2025
Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview) 18 January 2022
CyanConnode discuss record results, financial projection and priorities in 2022 (Interview) 18 January 2022
Kenmare Resources CEO: “almost US$100 million shareholder returns in 2021” (Interview) 14 January 2022
Scottish Mortgage Investment Trust Plc appoints Christopher Samuel as an independent NED 8 November 2024
Games Workshop Group grants exclusive rights to Amazon for Warhammer 40,000 universe films and series 10 December 2024
Sequoia Economic Infrastructure Income Fund appoints Paul Le Page as Senior Independent NED 9 December 2024
Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL) 16 February 2022
Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY) 14 February 2022
Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital 7 October 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 29 September 2020
GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital 25 September 2020
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 35% Upside Potential with Strong Buy Ratings 20 January 2026
Auction Technology Group PLC (ATG.L) Stock Analysis: Navigating the 26.51% Upside Potential 20 January 2026
Hilton Food Group PLC (HFG.L) Investor Outlook: 52.39% Potential Upside Highlights Growth Prospects 20 January 2026
Baltic Classifieds Group PLC (BCG.L) Stock Analysis: Unlocking a Potential 41% Upside 20 January 2026
